Streptomyces aureofaciens Duggar (12749)

Strain Designations: S1308-29  /  Type Strain: no  /  Biosafety Level: 1

Permits And Restrictions

View Permits

Strain Designations S1308-29
Application
Produces 6-demethyltetracycline
Produces 7-chloro-5a (11a)-dehydrotetracycline
Produces 7-chloro-t-demethyltetracycline
Produces alpha(11 alpha)-dehydrotetracyclines
Produces chlortetracycline aureomycin
Produces tetracycline
Produces tetracyclines
Type Strain no
Biosafety Level 1

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format freeze-dried
Preceptrol® no
Type Strain no
Medium ATCC® Medium 196: Yeast malt extract agar
Growth Conditions
Temperature: 26.0°C
Name of Depositor Lederle Labs.
U.S. Patent Number
Disclosure This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished.
References

Miller PA, McCormick JR. Biological transformation of anhydrotetracycline to 5alpha(11alpha)-dehydrotetracyclines. US Patent 2,952,587 dated Sep 13 1960

McCormick JR, et al. Process of producing an antibiotic of the tetracycline series. US Patent 2,970,947 dated Feb 7 1961

Miller PA, Growich JA Jr.. New tetracyclines produced by Streptomyces aureofaciens. US Patent 3,007,965 dated Nov 7 1961

McCormick JR, et al. Production of tetracyclines. US Patent 2,998,352 dated Aug 29 1961

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation